Abstract
Objective There is a growing interest in functional near-infrared spectroscopy (fNIRS) among researchers due to its remarkable advantages such as ease of use, being inexpensive and less tolerance to motion artifacts compared to other neuroimaging modalities. Also, its interaction with machine learning (ML) approaches was inevitable like other neuroimaging modalities for different purposes such as diagnostic classification of diseases or prediction of disease severity due to the lack of robust and objective biomarkers. A review of literature is carried out to understand the evolution of biomarker research on clinical populations and clinical states by combining fNIRS and ML.
Approach In this review, article search was carried out in accordance with the Preferred Reporting Items for Systematic reviews and Meta-Analyses (PRISMA) standard and 62 studies were evaluated and we provided a general overview by using fNIRS, particularly in clinical populations and some clinically relevant conditions on healthy populations. Also, potential biomarkers that were found in these studies and some popular ML algorithms that had been used for the prediction or classification of fNIRS data were discussed.
Main Results There is an increasing trend to perform ML applications on fNIRS data on biomarker research related to different clinical fields. Among these studies, few were able to have a notable number of participants for classification and clinical state prediction. Oxy-hemoglobin was used more than deoxy-hemoglobin in ML-based studies as a potential feature source.
Significance Using ML on fNIRS data might be a promising approach to revealing specific biomarkers for either diagnostic classification of diseases or prediction of clinical conditions.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
This study did not receive any funding
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Data Availability
All data produced in the present study are available upon reasonable request to the authors.